Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HSAI | IMNM |
|---|---|---|
| Price | $15.91 | $21.17 |
| Change today | ▲ 3.45% | ▲ 1.29% |
| Market cap | $2.50B | $2.50B |
| Return, 3 months | -1.5% | -13.2% |
| Return, year to date | -29.0% | -1.4% |
| Return, 1 year | -41.2% | +46.9% |
| P/E (TTM) | 31.6 | -8.4 |
| P/B | 1.9 | 4.8 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -100.0% |
| Net profit growth (YoY) | – | -68.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +79.9% | +67.2% |
| Analyst buy share | 100% | 91% |
| RSI (14) | 44 | 33 |
| 30-day volatility | 60.3% | 45.3% |
| Max drawdown, 1 year | -50.6% | -33.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
